Study: MDMA therapy for PTSD shows positive results 04:26. The Food and Drug Administration declined Friday to approve an application to treat post-traumatic stress disorder using the drug ...

An FDA panel rejected MDMA-based treatments for PTSD often used with veterans. One advocate shared what the verdict means for the future of mental health care, while doctors stressed supervision.

If approved, MDMA-AT would be the first psychedelic-based therapeutic cleared by the FDA for any condition in the US and the first PTSD medication to receive approval in 24 years.

In June, the FDA's Psychopharmacologic Drugs Advisory Committeevoted 9-2 against MDMA as an effective treatment for PTSD patients, and 10-1 that the drug's benefits do not outweigh the risks.

HEALTH FDA rejects MDMA as psychedelic-based treatment for mental health, PTSD The agency has requested that Lykos Therapeutics conduct another Phase 3 trial to confirm safety and efficacy ...

The U.S. Food and Drug Administration (FDA) has decided not to approve a psychedelic treatment -- along with therapy -- to treat post-traumatic stress disorder (PTSD), according to Lykos ...

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of ...

FDA advisers reject MDMA therapy for PTSD, amid concerns over research. Updated June 4, 2024 8:10 PM ET Originally published June 4, 2024 6:24 PM ET. Heard on All Things Considered. By .

Despite the FDA's rejection of MDMA-assisted therapy, Lykos Therapeutics plans to push ahead for approval, despite internal turmoil and layoffs of 75% of company staff.

There are only two FDA-approved treatments for PTSD. MDMA would be the first to come on the market in decades. Though classified as a Schedule I drug, the FDA granted MDMA "breakthrough therapy ...

FDA rejects MDMA for treating PTSD, calls for redo of study, drugmaker says. Story by Alexander Tin • 9mo. T he Food and Drug Administration declined Friday to approve an application to treat ...

WASHINGTON — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using ...